Several new 1H-pyrazolo [3,4-b]quinoxaline derivatives with N,N-dialkylamino electron-donating groups were prepared; their photoluminescence in solution and electroluminescence in thin-film devices have been investigated. They show emission at 520-540 nm with a fluorescence quantum yield close to unity in moderately polar solvents. The absorption and emission maxima shift to red with increasing solvent polarity. The fluorescence quantum yield also increases with increasing solvent polarity from non-polar to moderately polar solvents, then decreases slightly with further increase of solvent polarity. It indicates that both ''positive'' and ''negative'' solvatokinetic effects co-exist. The electroluminescence of OLED devices fabricated by using these compounds as dopants was investigated. All devices with the configuration of indium-tin oxide coated glass/ NPB (60 nm)/Alq 3 : Dopant (30 nm)/Alq 3 (20 nm)/Mg : Ag (200 nm) show bright green emission with efficiencies of 7.5-9.7 cd A 21 and narrow full bandwidth at half intensity of 68-75 nm peaking at 536-552 nm.
4-Dicyanomethylene-chromene moiety has been introduced as a π-electron acceptor in red fluorescent dye molecules for organic light-emitting devices (OLEDs). On the basis of this moiety, a new family of red dopants with saturated emission, higher fluorescent quantum yield, and convenient synthetic procedures have been designed and synthesized. Their photoluminescent and electroluminescent properties have been examined and compared. On the basis of the results, useful guidelines for the molecular design of saturated redemission fluorescent dopants for OLED applications are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.